FDA Inspection 1216536 — Entrogen, Inc
The FDA completed an inspection of Entrogen, Inc on July 31, 2023 in Woodland Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Woodland Hills, CA (United States)